Peripherin-IgG association with neurologic and endocrine autoimmunity

Journal of Autoimmunity

Volumn 34, Issue 4, 2010, Pages 469-477

  Chamberlain, Jayne L ^a   Pittock, Sean J ^b   Oprescu, Anna Maria ^a   Dege, Carissa ^a   Apiwattanakul, Metha ^b   Kryzer, Thomas J ^b   Lennon, Vanda A ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

Author keywords

Autoimmune endocrinopathy; Dysautonomia; NOD mice; Peripheral neuropathy

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PERIPHERIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DYSAUTONOMIA; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL MOTILITY DISORDER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE INNERVATION; MALE; NERVE TRACT; NONHUMAN; PERIPHERAL NEUROPATHY; PREDICTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE; THYROIDITIS;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; BIOLOGICAL MARKERS; ENDOCRINE SYSTEM; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; INTERMEDIATE FILAMENT PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROIMMUNOMODULATION; PRIMARY DYSAUTONOMIAS; RATS;

EID: 77952236568     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.12.004     Document Type: Article

References (35)

1. Lindstrom J.M., Seybold M.E., Lennon V.A., Whittingham S., Duane D.D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 1976, 26:1054-1059.
2. Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000, 343:847-855.
3. Hinson S.R., Roemer S.F., Lucchinetti C.F., Fryer J.P., Kryzer T.J., Chamberlain J.L., et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 2008, 205:2473-2481.
4. Geschwind M.D., Tan K.M., Lennon V.A., Barajas R.F., Haman A., Klein C.J., et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 2008, 65:1341-1346.
5. Dhamija R., Tan K.M., Pittock S.J., Foxx-Orenstein A., Benarroch E., Lennon V.A. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol 2008, 6:988-992.
6. Lai M., Hughes E.G., Peng X., Zhou L., Gleichman A.J., Shu H., et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009, 65:424-434.
7. Solimena M., Folli F., Denis-Donini S., Comi G.C., Pozza G., De Camilli P., et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 1988, 318:1012-1020.
8. Saiz A., Arpa J., Sagasta A., Casamitjana R., Zarranz J.J., Tolosa E., et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 1997, 49:1026-1030.
9. Pittock S.J., Yoshikawa H., Ahlskog J.E., Tisch S.H., Benarroch E.E., Kryzer T.J., et al. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 2006, 81:1207-1214.
10. Dalmau J., Graus F., Rosenblum M.K., Posner J.B. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992, 71:59-72.
11. Sabater L., Titulaer M., Saiz A., Verschuuren J., Gure AO., Graus F. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 2008, 70:924-928.
12. Albert M.L., Darnell J.C., Bender A., Francisco L.M., Bhardwaj N., Darnell R.B. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 1998, 4:1321-1324.
13. Cikes N., Momoi M.Y., Williams C.L., Howard F.M., Hoagland H.C., Whittingham S., et al. Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of d-penicillamine or allogeneic bone marrow. Mayo Clin Proc 1988, 63:474-481.
14. Harper S., Mozdzanowski J., Speicher D. Two-dimensional gel electrophoresis. Current protocols in protein science 1998, 10.4.1-10.4.36. John Wiley & Sons, Inc, Hoboken. J.E. Coligan, B.M. Dunn, D.W. Speicher, P.T. Wingfield (Eds.).
15. Jimenez C.R., Huang L., Qiu Y., Burlingame A.L. In-gel digestion of proteins for MALDI-MS fingerprint mapping. Current protocols in protein science 1998, 16.4.1-16.4.5. John Wiley & Sons, Inc, Brooklyn. J.E. Coligan (Ed.).
16. Kapp E., Schutz F. Overview of tandem mass spectometry (MS/MS) database search algorithms. Current protocols in protein science 2007, 25.2.1-25.2.19. John Wiley & Sons, Inc. J.E. Coligan, B.M. Dunn, D.W. Speicher, P.T. Wingfield (Eds.).
17. Williams C.L., Lennon V.A. Striational autoantibodies: paraneoplastic antibodies associated with thymoma and myasthenia gravis. Clin Immunol Newsletter 1991, 11:161-170.
18. McLean J., Xiao S., Miyazaki K., Robertson J. A novel peripherin isoform generated by alternative translation is required for normal filament network formation. J Neurochem 2008, 104:1663-1673.
19. Pittock S.J., Kryzer T.J., Lennon V.A. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 2004, 56:715-719.
20. Lennon V.A., Sas D.F., Busk M.F., Scheithauer B., Malagelada J.R., Camilleri M., et al. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 1991, 100:137-142.
21. Knowles C.H., Lang B., Clover L., Scott S.M., Gotti C., Vincent A., et al. A role for autoantibodies in some cases of acquired non-paraneoplastic gut dysmotility. Scand J Gastroenterol 2002, 37:166-170.
22. Pasha S.F., Lunsford T.N., Lennon V.A. Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology 2006, 131:1592-1596.
23. Kraichely R.E., Farrugia G., Pittock S.J., Castell D.O., Lennon V.A. Neural autoantibody profile of primary achalasia. Dig Dis Sci Jun 5, 2009, [Epub ahead of print].
24. Yu Z., Kryzer T.J., Griesmann G.E., Kim K., Benarroch E.E., Lennon V.A. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001, 49:146-154.
25. Lennon V.A., Ermilov L.G., Szurszewski J.H., Vernino S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest 2003, 111:907-913.
26. Vernino S., Lennon V.A. Autoantibody profiles and neurological correlations of thymoma. Clin Can Res 2004, 10:7270-7275.
27. Eriksson K.S., Zhang S., Lin L., Lariviere R.C., Julien J.P., Mignot E. The type III neurofilament peripherin is expressed in the tuberomammillary neurons of the mouse. BMC Neurosci 2008, 9:26.
28. Oblinger M.M., Wong J., Parysek L.M. Axotomy-induced changes in the expression of a type III neuronal intermediate filament gene. J Neurosci 1989, 9:3766-3775.
29. Lariviere R.C., Nguyen M.D., Ribeiro-da-Silva A., Julien J.P. Reduced number of unmyelinated sensory axons in peripherin null mice. J Neurochem 2002, 81:525-532.
30. Carrillo J., Puertas M.C., Alba A., Ampudia R.M., Pastor X., Planas R., et al. Islet-infiltrating B-cells in nonobese diabetic mice predominantly target nervous system elements. Diabetes 2005, 54:69-77.
31. Puertas M.C., Carrillo J., Pastor X., Ampudia R.M., Planas R., Alba A., et al. Peripherin is a relevant neuroendocrine autoantigen recognized by islet-infiltrating B lymphocytes. J Immunol 2007, 178:6533-6539.
32. Carrillo J., Puertas M.C., Planas R., Pastor X., Alba A., Stratmann T., et al. Anti-peripherin B lymphocytes are positively selected during diabetogenesis. Mol Immunol 2008, 45:3152-3162.
33. Boitard C., Villa M.C., Becourt C., Gia H.P., Huc C., Sempe P., et al. Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products. Proc Natl Acad Sci U S A 1992, 89:172-176.
34. Ahren B. Autonomic regulation of islet hormone secretion - implications for health and disease. Diabetologia 2000, 43:393-410.
35. Winer S., Tsui H., Lau A., Song A., Li X., Cheung R.K., et al. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat Med 2003, 9:198-205.